Taro's PE Backers Balk At Sun Pharma's $600M Buyout
Two private equity firms holding sizable minority stakes in Taro Pharmaceutical Industries Ltd. sent a letter to the company on Friday demanding more information about its approval of a $600 million...To view the full article, register now.
Already a subscriber? Click here to view full article